Glucocorticoid receptors in human airways
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Inhaled and intranasal glucocorticoids are the most common and effective drugs for controlling symptoms and airway inflammation in respiratory diseases such as asthma, allergic rhinitis, and nasal polyposis. The last few years have seen a growing understanding of the mechanisms of glucocorticoid action and, in particular, the receptor that mediates glucocorticoid actions, the glucocorticoid receptor (GR). In this revision we present an update on the GR gene, the expression and regulation of its gene products, namely GR α and GR β, as well as their alterations in pathological states. GR α is responsible for the induction and repression of target genes, it is expressed in virtually all human cells and tissues, and its expression is known to be downregulated by glucocorticoids. GR β has been found to act as a dominant negative inhibitor of GR α‐mediated transactivation in in vitro studies with transfected cells, but it does not appear to have a significant inhibitory effect on GR α‐mediated transrepression. In addition, for most tissues the expression of GR β, at least at the mRNA level, is extremely low compared with that of GR α. Some pro‐inflammatory cytokines appear to upregulate the expression of GR β, and increased GR β expression has been reported in diseases associated with glucocorticoid resistance or insensitivity, such as bronchial asthma, nasal polyposis, and ulcerative colitis. However, the possible role of GR β in modulating glucocorticoid sensitivity and/or resistance in vivo has been highly debated and it is not yet clear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390 · cited 1×
“For instance, activated GRa upregulates the expression of the cytoplasmic NF-jB inhibitor IjB in certain cell types, which prevents nuclear translocation and DNA binding of NF-jB by its retention in the cytoplasm (46, 47).”
BackgroundSteroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 3×
“Other post-translational modifications that have been shown to alter GR function are ubiquitinylation, sumoylation and nitrosylation (24, 25).”
BackgroundScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
Hauk, P. J., Hamid, Q. A., Chrousos, G. P., & Leung, D. Y. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105807 · Cited by 202 · cited 3×
“Different proinflammatory stimuli, such as TNF-a, IL-1, or bacterial superantigens, have been shown to induce a mild increase in GRa expression in a variety of cell types (20, 84, 85) (Table 2).”
BackgroundNovel glucocorticoid receptor coactivator effector mechanisms
Jenkins, B. D., Pullen, C. B., & Darimont, B. D. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00357-x · Cited by 150 · cited 1×
“For instance, the coactivators CREB (cyclic adenosine monophosphate response element-binding protein)-binding protein (CBP), p300/CBP-associated factor (p/CAF), steroid receptor coactivator-1 (SRC-1) and glucocorticoid receptor-interacting protein-1 (GRIP-1) interact with the s1 and s2 domains of GRa and, through thei…”
BackgroundNasal involvement in allergic asthma
Braunstahl, G. ‐., & Fokkens, W. (2003) · Allergy · doi:10.1046/j.0105-4538.2003.00354.x · Cited by 102
Cited by
Corticosteroid Treatment in Chronic Rhinosinusitis: The Possibilities and the Limits
Mullol, J., Obando, A., Pujols, L., & Alobid, I. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.07.001 · Cited by 105
Self-citationAirway smooth muscle as an immunomodulatory cell
Damera, G., Tliba, O., & Panettieri, R. A. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.006 · Cited by 98
Cytokines Alter Glucocorticoid Receptor Phosphorylation in Airway Cells
Bouazza, B., Krytska, K., Debba-Pavard, M., Amrani, Y., Honkanen, R. E., Tran, J., & Tliba, O. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0364oc · Cited by 61
Takabe, S., Mochizuki, K., & Goda, T. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.036 · Cited by 37
Metadata
- Authors
- Pujols, L., Mullol, J., Torrego, A., & Picado, C.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2004-09-07
- Volume
- 59
- Issue
- 10
- Pages
- 1042-1052
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1979072908
- Cited by
- 98
- References
- 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.